Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
220.7 USD | -1.04% | -5.01% | -6.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.45% | 11.49B | |
+42.10% | 54.04B | |
+43.57% | 41.96B | |
-1.20% | 41.92B | |
-7.59% | 28.35B | |
+12.21% | 26.35B | |
-22.56% | 19B | |
+7.81% | 13B | |
+28.86% | 12.28B | |
+25.16% | 12.19B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- UBS Cuts Charles River Laboratories International Price Target to $215 From $250, Maintains Buy Rating